Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study

The Basis of Oncoimmunology

(2016) A. Karolina Palucka et al.   CELL

Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+T cells for adoptive immunotherapy of cancer and infections

(2016) A. N. Hasan et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia

(2016) Aizhang Xu et al.   Cell and Bioscience

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

(2015) Jeong-Hoon Lee et al.   BRITISH JOURNAL OF CANCER

IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy

(2015) K. Pilipow et al.   CANCER RESEARCH

Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma

(2015) Joon Hyeok Lee et al.   GASTROENTEROLOGY

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

(2015) Kevin C. Conlon et al.   JOURNAL OF CLINICAL ONCOLOGY

Precision Measurement of the Helium Flux in Primary Cosmic Rays of Rigidities 1.9 GV to 3 TV with the Alpha Magnetic Spectrometer on the International Space Station

(2015) M. Aguilar et al.   PHYSICAL REVIEW LETTERS

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

(2015) E. Vacchelli et al.   SCIENCE

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Dendritic-Cell-Based Therapeutic Cancer Vaccines

(2013) Karolina Palucka et al.   IMMUNITY

Design and development of therapies using chimeric antigen receptor-expressing T cells

(2013) Gianpietro Dotti et al.   IMMUNOLOGICAL REVIEWS

Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma

(2013) Jiuwei Cui et al.   INTERNATIONAL JOURNAL OF CANCER

Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2012) C. Verslype et al.   ANNALS OF ONCOLOGY

Interleukin 15 Provides Relief to CTLs from Regulatory T Cell-Mediated Inhibition: Implications for Adoptive T Cell-Based Therapies for Lymphoma

(2012) S. K. Perna et al.   CLINICAL CANCER RESEARCH

T Cell Assays and MIATA: The Essential Minimum for Maximum Impact

(2012) C.M. Britten et al.   IMMUNITY

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

(2012) FUJIMASA TADA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Harnessing dendritic cells in cancer

(2011) Lionel Apetoh et al.   SEMINARS IN IMMUNOLOGY

The dendritic cell–tumor cross-talk in cancer

(2010) Yuting Ma et al.   CURRENT OPINION IN IMMUNOLOGY

Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma

(2009) Eduardo Huarte et al.   CANCER LETTERS

Efficacy of IL-2-versusIL-15-stimulated CD8 T cells in adoptive immunotherapy

(2008) Katja Mueller et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma

(2008) Daniel H. Palmer et al.   HEPATOLOGY

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute